Ziyou Lin

2.2k citations

15 papers · 1.6k indexed · 3 hit papers · h-index 10

Impact in

Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology top 5%
- RNA modifications and cancer
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- RNA Research and Splicing

Papers in

Cancer Research 8
- Cancer-related molecular mechanisms research 6
- Cancer, Hypoxia, and Metabolism 3
Molecular Biology 11
- RNA modifications and cancer 9
- Epigenetics and DNA Methylation 2
- Circular RNAs in diseases 2

Co-authors: Guohui Wan Yi Niu Arabella Wan Heng Liang Lei Sun Xiaolei Zhang Xianzhang Bu Weiling He
Journals: Molecular Therapy (1 paper)Acta Pharmaceutica Sinica B (1 paper)Cell Death and Disease (1 paper)Functional & Integrative Genomics (1 paper)Gut (1 paper)
Partner nations: China United States Macao

In The Last Decade

Ziyou Lin

11 papers receiving 1.6k citations

Hit Papers

align trajectories log scale

Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer 2022 · 323 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Redox Biology
2020 The EMBO Journal
2019 Molecular Cancer

Peers

Countries citing papers authored by Ziyou Lin

Since Specialization

Citations

This map shows the geographic impact of Ziyou Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziyou Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziyou Lin more than expected).

Fields of papers citing papers by Ziyou Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziyou Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziyou Lin. The network helps show where Ziyou Lin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ziyou Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ziyou Lin Line = papers co-authored together Ziyou Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	Gender-stratified analysis of sepsis mortality in cancer: a 45-year population-based cohort study JNCI Cancer Spectrum ·Yadong Guo, Ziyou Lin, Wentao Zhang, Haotian Chen, Yongqiang Liu, Ji Liu, Junfeng Zhang, Ai-Hong Zhang, Shiyu Mao, Xudong Yao	2025	0
2	Comprehensive multi-omics analysis of nucleotide metabolism: elucidating the role and prognostic significance of UCK2 in bladder cancer Functional & Integrative Genomics ·Yadong Guo, Ziyou Lin, Wentao Zhang, Haotian Chen, Yuxin Chen, Yongqiang Liu, Zezhi Shan, Shiyu Mao, Xudong Yao	2025	3
3	The IGF2BP3–FASN axis drives lipid metabolic reprogramming to promote brain colonization in non-small cell lung cancer Cell Death and Disease ·С.Э. Майкова, Shumin Ouyang, Ziyou Lin, H. Gilbert, Nwaeze Chinweoke, Mei Lü, N. S. Tleugabulov, Jianshan Mo, 王鸿翔, Libin Wang, Peibin Yue, A Batrinac, Stefano Sormani, Yandong Wang, Xiaolei Zhang	2025	0
4	Oncogenic and immunological functions of USP35 in pan-cancer and its potential as a biomarker in kidney clear cell carcinoma BMC Cancer ·Yadong Guo, Ziyou Lin, Ziyang Zhou, Wentao Zhang, Shiyu Mao, Zezhi Shan, Pengfei Wu, Xudong Yao	2025	0
5	KLRD1 (CD94): A Prognostic Biomarker and Therapeutic Candidate in Head and Neck Squamous Cell Carcinoma Journal of Cancer ·C Tabeling, Ziyou Lin, (unknown), Qun Lu	2024	0
6	Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non–Small Cell Lung Cancer Cancer Research ·Ziyou Lin, С.Э. Майкова, Jian Zhang, Weineng Feng, Jiaye Lu, 李凤善, Ma. Dolores Elizalde, Shumin Ouyang, Jin‐Jian Lu, Peibin Yue, Guohui Wan, Peiqing Liu, Xiaolei Zhang	2023	75
7	Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer Cancer Letters ·Jiaye Lu, (unknown), Jingwei Li, Ziyou Lin, Huaxuan Li, Linlin Lou, Wen Ding, Shumin Ouyang, 方进元, H.M. Liu, Xiaobing Chen, Peibin Yue, Yuanxiang Wang, Peiqing Liu, (unknown), (unknown), Jian Zhang, Weineng Feng, Xiaolei Zhang	2023	57
8	Discovery and Optimization of Novel Biphenyl Derivatives Bearing Cyclopropyl Linkage as Potent Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors Journal of Medicinal Chemistry ·李阳海, Sae-Jin Hong, Zhenghui Kang, Jianshan Mo, アンドレアスバーナー, Ziyou Lin, Xiang Fu, Chang Liu, Hang Ma, Xiaolei Zhang, Wenhao Hu	2023	17
9	N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis Molecular Therapy ·Ziyou Lin, Arabella Wan, Lei Sun, Heng Liang, Yi Niu, Yuan Deng, Shijia Yan, Qiao‐Ping Wang, Xianzhang Bu, Xiaolei Zhang, Kunhua Hu, Guohui Wan, Weiling He	2022	56
10	Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer Redox Biology ·Shumin Ouyang, Huaxuan Li, Linlin Lou, Joseph Fulkerson, Zhenhua Zhang, Jianshan Mo, Min Li, Jiaye Lu, Kai Zhu, Yunjie Chu, Wen Ding, Jianzheng Zhu, Ziyou Lin, Lin Zhong, Junjian Wang, Peibin Yue, James Turkson, Peiqing Liu, Yuanxiang Wang, Xiaolei Zhang Hit paper breakdown →	2022	323
11	Loss‐of‐Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia Hepatology ·Yi Niu, Ziyou Lin, Arabella Wan, Lei Sun, Shijia Yan, Heng Liang, Yira Molinar, Dongshi Chen, Xianzhang Bu, Peiqing Liu, Ceshi Chen, Weiling He, Xiongbin Lu, Guohui Wan	2021	91
12	RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer Gut ·Lei Sun, Arabella Wan, Zhuolong Zhou, Dongshi Chen, Heng Liang, Chuwei Liu, Shijia Yan, Yi Niu, Ziyou Lin, Yira Molinar, Shanfeng Wang, Xianzhang Bu, Weiling He, Xiongbin Lu, Anlong Xu, Guohui Wan	2020	86
13	RNA m ⁶ A methylation regulates sorafenib resistance in liver cancer through FOXO 3‐mediated autophagy The EMBO Journal ·Ziyou Lin, Yi Niu, Arabella Wan, Dongshi Chen, Heng Liang, Xijun Chen, Lei Sun, Yira Molinar, Liutao Chen, Chao Cheng, Xiaolei Zhang, Xianzhang Bu, Weiling He, Guohui Wan Hit paper breakdown →	2020	359
14	RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3 Molecular Cancer ·Yi Niu, Ziyou Lin, Arabella Wan, Honglei Chen, Heng Liang, Lei Sun, Yuan Wang, Xi Li, Xiao‐Feng Xiong, Bo Wei, Xiaobin Wu, Guohui Wan Hit paper breakdown →	2019	455
15	N6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development Acta Pharmaceutica Sinica B ·Yi Niu, Arabella Wan, Ziyou Lin, Xiongbin Lu, Guohui Wan	2018	68

About Ziyou Lin

Ziyou Lin is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 15 papers that have together received 1.6k indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (6 papers), Cancer, Hypoxia, and Metabolism (3 papers), Ferroptosis and cancer prognosis (3 papers), Phagocytosis and Immune Regulation (2 papers), Epigenetics and DNA Methylation (2 papers), Circular RNAs in diseases (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Cancer Research (825 citations), Molecular Biology (1.3k citations), Pulmonary and Respiratory Medicine (284 citations), Oncology (221 citations) and Immunology (114 citations). Ziyou Lin has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Guohui Wan, Yi Niu, Arabella Wan, Heng Liang, Lei Sun, Xiaolei Zhang, Xianzhang Bu, Weiling He, Honglei Chen and Dongshi Chen. Their work appears in journals such as Molecular Therapy, Acta Pharmaceutica Sinica B, Cell Death and Disease, Functional & Integrative Genomics and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact